PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy

Table 1

Selected demographic and clinical characteristics of patients with CRCs.

Clinicopathological factors	Number of patients	Recurrence	value	Dead	value
	= 139	Number (%)		Number (%)
Age (years)		56		44
≥65	53 (38.1%)	22/53 (41.5%)	0.818	19/53 (35.8%)	0.404
<65	86 (61.9%)	34/86 (39.5%)		25/86 (29.1%)
Sex
Male	85 (61.2%)	33/85 (38.8%)	0.659	25/85 (29.4%)	0.476
Female	54 (38.8%)	23/54 (42.6%)		19/54 (35.2%)
Tumor site
Rectum	67 (48.2%)	26/67 (38.8%)	0.731	19/67 (28.4%)	0.42
Colon	72 (51.8%)	30/72 (41.7%)		25/72 (34.7%)
Histology
Well/moderate	113 (81.3%)	43/113 (38.1%)	0.263	31/113 (27.4%)	0.026
Poor	26 (18.7%)	13/26 (50.0%)		13/26 (50.0%)
Lymph node metastasis
≥4	31 (22.3%)	18/31 (58.1%)	0.022	17/31 (54.8%)	0.002
<4	108 (77.7%)	38/108 (35.2%)		27/108 (25.0%)
TNM stage
IIIA	13 (9.4%)	2/13 (15.4%)	0.001	1/13 (7.7%)	0.004
IIIB	99 (71.2%)	35/99 (35.4%)		28/99 (28.3%)
IIIC	27 (19.4%)	19/27 (70.4%)		15/27 (55.6%)

Bold items highlight ; TNM: tumor node metastasis.